Navigation Links
China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc.
Date:4/24/2008

HARBIN, China, April 24 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (OTC Bulletin Board: CSKI), a pharmaceutical company for external use over-the-counter drugs in the People's Republic of China ("PRC"), today announced it acquired Heilongjiang Haina Pharmaceutical Inc. ("Haina Pharmaceutical"), a recently formed corporation organized under the laws of the PRC on April 18, 2008.

China Sky One Medical, Inc., through its indirect wholly owned subsidiary Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), consummated a transaction pursuant to an Equity Transfer Agreement with Heilongjiang Haina Pharmaceutical Inc., licensed as a wholesaler of traditional Chinese medicine, bio-medicines, bio-products, medicinal devices, antibiotics and chemical medicines.

Pursuant to the Equity Transfer Agreement, Harbin acquired 100% of the issued and outstanding capital stock of Haina Pharmaceutical from its three stockholders in consideration for payment of 3,000,000 RMB (approximately $428,571). TDR has been overseeing the operations of Haina Pharmaceutical since January 2008 as part of its due diligence prior to closing of this acquisition.

Haina Pharmaceutical does not have an established sales network and was acquired for its primary asset, a Good Supply Practice (GSP) license issued as of December 21, 2006 by the Heilongjiang office of the SFDA, and will expire on January 29, 2012. The SFDA recently started issuing such licenses to resellers of medicines in order to maintain certain quality controls. The GSP license enables China Sky One Medical to expand its sales of medicinal products without having to go through a lengthy license application process.

"We are pleased to complete the acquisition of Haina Pharmaceutical. By obtaining the GSP license, we now have the ability to further develop our sales channels in a timely manner," said Mr. Yan-qing Liu, Chairman, CEO an
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Syngenta To Build Major Global Biotech Research Center in Beijing, China
2. American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance
3. China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier
4. CTDC Attends the Inauguration Ceremony of Thin Film A-Si Manufacturing Line in Changzhou, China
5. China Bio Energy Reports Fiscal 2007 Financial Results
6. Transgenomic Opens Pharmacogenomics Laboratory in China
7. China Pharma Holdings, Inc. Announces Record 2007 Year End Results
8. China Kangtai Cactus Biotech, Inc. Obtains $500,000 Equity Financing
9. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China
10. Aida Acquires High-Level Research Institute in China
11. China Pharma Holdings, Inc. Announces Earnings Call for Fiscal 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ovember 20 Karolinska Development ...nd (EIF) has entered into a,co-investment agreemen...,managed by Karolinska Development and used to inv...maceutical and medical technology companies. EIF,h...ent fund. The agreement,represents EIF,s largest s...
(Date:11/19/2009)...PRNewswire/ -- Danish Prince Joachim inaugurated t...t in Kalundborg, Denmark, on Wednesday, November 1...rgest 2nd generation ethanol demonstration biorefi... the plant,s innovative process for converting str...he first to market with commercial enzymes for con...
(Date:11/19/2009)...19 Spherix Incorporated ...r diabetes therapy, and a provider of technical an...nt, biotechnology and pharmaceutical companies, to...ing of Shareholders. ,, At the meeting, shareho...cted the following members to the Board of Directo...
(Date:11/19/2009)...,s Top Gene Synthesis Companies Form International...st Practices in Risk Reduction ,Five Member Comp...esis Capacity , (PRWEB) N...ing gene synthesis companies today announced agree...col to promote biosecurity in the gene synthesis i...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
... SUNNYVALE, Calif., Jan. 14 Accuray Incorporated,... radiosurgery, today announced,that it will report...ending,December 27, 2008, on Thursday, January 29,...call to review the results will begin at 2:00 p.m.... Thomson, Ph.D., president and chief,executive off...
... LEOMINSTER, Mass., Jan. 14 PolyOrg, Inc. a Massa... non-exclusive license agreement with,the Copenhag...ure and,distribute PNA monomers worldwide. , "... license to sell PNA,monomers," said Peter Nielsen...n , Denmark and co-inventor of PNA. "Ready availab...
... Comprehensive tutorials on t...d UniProt databases enable researchers to quickly ... Seattle (PRWEB) January 1...ility of new tutorial suites on PROSITE, InterPro ...l on UniProt. PROSITE is a database that can be ...
Other Biology Technology:Accuray Incorporated to Report Second Quarter Fiscal Year 2009 Financial Results 2PolyOrg, Inc. Acquires a License to Manufacture and Distribute PNA Monomers Worldwide 2New and Updated Online Tutorials for PROSITE, InterPro, IntAct and UniProt 2New and Updated Online Tutorials for PROSITE, InterPro, IntAct and UniProt 3
(Date:11/23/2009)..., , , , , , , , , , ... , , AUDIO: , Dr Andrew Mar...ersity of York, discusses the discovery of Kinyon... , Click here for more information... , , , , , , , ...
(Date:11/23/2009)..., , Scientists have revealed how environmental i... cause people to cough, in research published toda...ical Care Medicine . The authors of the study, fro...ll, have identified the reaction inside the lungs ... to particular irritants in the air. They suggest ...
(Date:11/23/2009)..., This release is available in German . , ...ce a long journey every year. Researchers at Princ...Institute for Ornithology in Radolfzell, Germany s...nt family of bats, the so-called "Vespertilionidae...vered that the migration over short as well as lon...
Breaking Biology News(10 mins):New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Research reveals exactly how coughing is triggered by environmental irritants 2We're off then: The evolution of bat migration 2Carnegie Mellon customizing electric cars for cost effective urban commuting 10732 1Carnegie Mellon customizing electric cars for cost effective urban commuting 10732 2Carnegie Mellon customizing electric cars for cost effective urban commuting 10732 3NeoVista Inc Announces the Launch of VIDION ANV Therapy System in UK for Treating Wet Age Related Macular Degeneration 61416 1NeoVista Inc Announces the Launch of VIDION ANV Therapy System in UK for Treating Wet Age Related Macular Degeneration 61416 2NeoVista Inc Announces the Launch of VIDION ANV Therapy System in UK for Treating Wet Age Related Macular Degeneration 61416 3Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 1Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 2Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 3Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 4
...share of grants totalling over 1m to target lung i...n Bates, a senior lecturer in the Department of En...cipient of 1,068,000 in the form of just two resea...Sciences Research Council (EPSRC) and the other fr...rch Council (BBSRC). , The grants are shared betw...
...nterior to determine if global warming threatens t...ot be used to justify listing the polar bear as an...blished later this year in Interfaces, a journal o...nagement Sciences (INFORMS)., On April 30, U.S. Di...epartment to decide by May 15 whether polar bears ...
...ess struggle to stay primed, researchers in Spain ...t and business practice is needed if a company is ...f Management Practice from Inderscience Publishers...e from nature to them restructure. , Palmira Lpez...rnando Fernndez-Gonzlez of the Hospital Central de...
Other Biology News:Engineer to spearhead research into cell metabolism and medical injuries 2Federal polar bear research critically flawed, says study in INFORMS journal 2Programmed death boosts business 2
...ve, cost-effective solution to your TechMate Detec...ted quality into both our products and service cap...ies and antibodies that have been optimized to the...vely priced accessories that can be purchased indi...
...is buffer, PCR mix, DNA polymerase and universal c...This system can detect different types of Gram neg... Escherichia Coli, Klebsiella Pneumoniae, Bacillus...actiae, and etc. With the powerful Universal lysis...
pTRI-GAPDH-Human (316 bp protected fragment) from Ambion
...timized for serum-free growth of Ready-Plaque Sf9 ... Sf9 cultures routinely reach densities greater th...is medium is also recommended for plaque assays, w...nants develops faster than other formulations. Cel...
Biology Products: